ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
What is the News?
Defence Research and Development Organization(DRDO) has developed an anti-COVID drug named 2-deoxy-D-glucose(2-DG). Recently, the Drugs Controller General of India(DCGI) has approved this drug for emergency use.
About 2-deoxy-D-glucose (2-DG):
- 2-deoxy-D-glucose (2-DG) is an anti-Covid oral drug. It has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO in collaboration with Dr Reddy’s Laboratories(DRL).
How does a 2-DG drug work?
- The 2-DG comes in powder form in the sachet. One has to take it orally by dissolving the powder in water.
- The drug accumulates in the virus-infected cells. It, thereby, prevents virus growth by stopping viral synthesis and energy production.
- The selective accumulation of the drug in virally infected cells makes this drug unique.
Significance of this drug:
- The drug helps in the faster recovery of hospitalised patients. Further, it also reduces supplemental oxygen dependence.
- A higher proportion of patients treated with 2-DG also showed RT-PCR negative conversion in Covid-19 patients.
Source: Indian Express
